BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression

B-cell lymphoma 9 (BCL9), a component of aberrantly activated Wnt signaling, is an important contributing factor to tumor progression. Our previous data indicated that downregulation of the tumor suppressor microRNA-30c (miR-30c) was a frequent pathogenetic event in prostate cancer (PCa). However, a...

Descripción completa

Detalles Bibliográficos
Autores principales: LING, XIAO-HUI, CHEN, ZHI-YUN, LUO, HONG-WEI, LIU, ZE-ZHEN, LIANG, YING-KE, CHEN, GUAN-XING, JIANG, FU-NENG, ZHONG, WEI-DE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774446/
https://www.ncbi.nlm.nih.gov/pubmed/26998113
http://dx.doi.org/10.3892/ol.2016.4161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774446/
https://www.ncbi.nlm.nih.gov/pubmed/26998113
http://dx.doi.org/10.3892/ol.2016.4161

Ejemplares similares